American Lung Association Calls for Urgent Flu Vaccination
As National Influenza Vaccination Week unfolds, the American Lung Association (ALA) has commenced a major campaign appealing to everyone aged six months and older to prioritize their annual flu vaccinations. This call comes on the heels of a particularly intense flu season, classified by the U.S. Centers for Disease Control and Prevention (CDC) as one of high severity—the most significant since the 2010-2011 flu season.
Flu, known scientifically as influenza, is a highly contagious respiratory illness that can result in severe health complications or even death, particularly among vulnerable populations. Individuals with chronic medical conditions, such as asthma or chronic obstructive pulmonary disease (COPD), face an increased risk of serious complications associated with flu infections.
Harold Wimmer, President and CEO of the ALA, stated, "Last year's flu season starkly illustrated the severe risks associated with influenza, especially for individuals with pre-existing lung diseases and other chronic health conditions. The flu shot represents our best defense against severe illness and fatalities. We strongly encourage those six months and older to make vaccination a priority this season."
Data released by the CDC reveals alarming insights into the 2024-2025 flu season:
- - The hospitalization rates were significantly higher than in previous years, marking the first high severity designation since the 2017-2018 season.
- - An estimated 43 million people were affected by flu-related illnesses, with 560,000 hospitalizations recorded and about 38,000 deaths attributed to the virus.
- - Disturbingly, 279 children lost their lives due to complications from the flu, marking the highest number of pediatric deaths since 2004.
Historically, a substantial percentage of adults hospitalized due to the flu had underlying health issues; conditions like chronic lung disease, heart disease, and diabetes are common factors contributing to increased flu risks. The flu can worsen existing chronic lung disease symptoms, exacerbate asthma episodes, and trigger serious COPD flare-ups.
The ALA insists that vaccination against the flu should ideally occur in September or October, ahead of the typical peak flu season from December to March. However, it remains beneficial to receive a flu vaccination later in the season, as long as the virus persists in communities. The flu shot can be safely administered alongside other vaccines, including those for respiratory syncytial virus (RSV) and COVID-19.
Through this campaign, the American Lung Association is working diligently to educate the public about influenza and the critical steps individuals can take to safeguard themselves and their families from severe illness and hospitalizations.
To explore additional information regarding flu prevention and lung protection strategies, please visit
Lung.org/prevent-flu.
This initiative receives supportive backing from Seqirus, highlighting the importance of collaboration in enhancing public health measures.
About the American Lung Association
The American Lung Association stands as the primary organization dedicated to improving lung health and preventing lung disease. The organization is focused on four strategic imperatives: eradicating lung cancer, advocating for clean air, enhancing the quality of life for those affected by lung disease, and fostering a tobacco-free future. With accolades including a 4-star rating from Charity Navigator, the ALA encourages public involvement and support through local events and initiatives. For more information, contact the ALA at 1-800-LUNGUSA (1-800-586-4872) or explore
Lung.org.